<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (APS) is defined by widespread arterial and venous thromboses associated with elevated plasma levels of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (APLA) </plain></SENT>
<SENT sid="1" pm="."><plain>The primary <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (PAPS) appear to be a fairly homogeneous disease, and HLA, family and other studies provide new insights into this cause of <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We describe two patients with PAPS (<z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> positive), whose family members were analyzed for clinical and <z:hpo ids='HP_0001939'>laboratory abnormalities</z:hpo> associated with APS </plain></SENT>
<SENT sid="3" pm="."><plain>Familial screening seems to be important, in order to prevent the thrombotic events </plain></SENT>
<SENT sid="4" pm="."><plain>Low dose aspirin is the first line treatment in asymptomatic subjects with APLA, previous or present <z:mp ids='MP_0005048'>thrombosis</z:mp> requiring long-term, possibly life-long anticoagulation </plain></SENT>
</text></document>